The firm adds CRISPR/Cas9 gene editing to its portfolio of plant genome engineering technologies, which also includes meganucleases and TALENs.
Seth Bordenstein of Vanderbilt University will use the award to find genes that respond to inherited bacterial infections in insects.
The findings further point to the importance of the stability and dosage of RNAi molecules to gene silencing in environmental RNAi-sensitive insects.
The researchers used RNAi and cDNA overexpression screens along with proteomics to map protein signaling linked to TRAIL-induced apoptosis.
Based in New York, the subsidiary will feature laboratory space to develop the firm's chimeric antigen receptor T cells for cancer immunotherapy.
In Science this week: measles virus nucleocapsid structure, and more.
African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.
Nature has retracted a 2002 epigenetics paper for image manipulation.
The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.